Windsor Group LTD Abbott Laboratories Transaction History

Windsor Group LTD

$546 Million
Q3 2023

A detailed history of Windsor Group LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Windsor Group LTD holds 16,310 shares of ABT stock, worth $1.92 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

16,310

Previous 16,310 -0.0%

Holding current value

$1.92 Million

Previous $1.78 Million 11.14%

% of portfolio

0.29%

Previous 0.32%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 12, 2023	BUY	$100.78 - $112.29 $6,853 - $7,635	68 Added 0.42%	16,310 $1.78 Million
Q4 2022 Feb 01, 2023	BUY	$95.06 - $111.52 $2,756 - $3,234	29 Added 0.18%	16,242 $1.82 Million
Q3 2022 Nov 07, 2022	SELL	$96.76 - $112.03 $3,773 - $4,369	-39 Reduced 0.24%	16,213 $1.65 Million
Q2 2022 Aug 08, 2022	SELL	$102.07 - $123.37 $911,280 - $1.1 Million	-8,928 Reduced 35.46%	16,252 $1.77 Million
Q1 2022 May 04, 2022	BUY	$114.02 - $139.04 $14,708 - $17,936	129 Added 0.51%	25,180 $3.1 Million
Q4 2021 Jan 21, 2022	BUY	$115.53 - $141.46 $23,337 - $28,574	202 Added 0.81%	25,051 $3.4 Million
Q3 2021 Oct 12, 2021	BUY	$116.66 - $129.06 $93,911 - $103,893	805 Added 3.35%	24,849 $2.91 Million
Q2 2021 Jul 26, 2021	BUY	$105.79 - $124.53 $24,754 - $29,140	234 Added 0.98%	24,044 $2.79 Million
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $31,672 - $37,314	291 Added 1.24%	23,810 $2.85 Million
Q4 2020 Feb 09, 2021	SELL	$105.0 - $114.42 $37,800 - $41,191	-360 Reduced 1.51%	23,519 $2.58 Million
Q3 2020 Nov 06, 2020	BUY	$91.64 - $111.29 $82,750 - $100,494	903 Added 3.93%	23,879 $2.6 Million
Q2 2020 Jul 06, 2020	BUY	$76.57 - $98.0 $24,042 - $30,772	314 Added 1.39%	22,976 $2.1 Million
Q1 2020 Apr 13, 2020	BUY	$62.82 - $91.86 $10,616 - $15,524	169 Added 0.75%	22,662 $1.79 Million
Q4 2019 Jan 07, 2020	BUY	$78.51 - $87.4 $11,540 - $12,847	147 Added 0.66%	22,493 $1.95 Million
Q3 2019 Oct 21, 2019	BUY	$81.84 - $88.74 $189,295 - $205,255	2,313 Added 11.55%	22,346 $1.87 Million
Q2 2019 Jul 15, 2019	BUY	$72.88 - $85.0 $918,798 - $1.07 Million	12,607 Added 169.77%	20,033 $1.69 Million
Q1 2019 Apr 09, 2019	BUY	$66.22 - $80.06 $11,124 - $13,450	168 Added 2.31%	7,426 $594,000
Q4 2018 Jan 15, 2019	BUY	$65.56 - $74.27 $28,190 - $31,936	430 Added 6.3%	7,258 $525,000
Q3 2018 Oct 05, 2018	BUY	$60.81 - $73.36 $126,910 - $153,102	2,087 Added 44.02%	6,828 $501,000
Q2 2018 Jul 31, 2018	SELL	$57.57 - $63.54 $5,757 - $6,354	-100 Reduced 2.07%	4,741 $289,000
Q1 2018 May 09, 2018	SELL	$56.27 - $63.62 $2,250 - $2,544	-40 Reduced 0.82%	4,841 $290,000
Q4 2017 Mar 01, 2018	BUY	$53.68 - $57.47 $262,012 - $280,511	4,881	4,881 $279,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Windsor Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Windsor Group LTD with notifications on news.

Account

Windsor Group LTD Abbott Laboratories Transaction History